Triple negative breast cancer: Breast cancer research in evolution

作者: Jennifer Eng-Wong , Sally Hunsberger , Jo Anne Zujewski

DOI: 10.3233/BD-2010-0314

关键词:

摘要: A 2011 Pubmed search on the terms “breast cancer” and “triple negative” identified 932 articles, thus interest in this topic since classification of triple negative/basal-like breast cancer has exploded a number recent informative reviews have been published [1–3]. We envision special edition Breast Disease focused negative (TNBC) as “go-to” handbook accessible to clinical, translational laboratory researchers designing (and interpreting) studies cancer. This issue contains in-depth multiple aspects TNBC from cell lines current clinical trials. We, editors, would like thank authors for their excellent contributions highlight over arching issues.

参考文章(15)
Lisa Carey, Eric Winer, Giuseppe Viale, David Cameron, Luca Gianni, Triple-negative breast cancer: disease entity or title of convenience? Nature Reviews Clinical Oncology. ,vol. 7, pp. 683- 692 ,(2010) , 10.1038/NRCLINONC.2010.154
Sabine C. Linn, Laura J. Van 't Veer, Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept European Journal of Cancer. ,vol. 45, pp. 11- 26 ,(2009) , 10.1016/S0959-8049(09)70012-7
Edward L. Korn, Boris Freidlin, Jeffrey S. Abrams, Overall Survival As the Outcome for Randomized Clinical Trials With Effective Subsequent Therapies Journal of Clinical Oncology. ,vol. 29, pp. 2439- 2442 ,(2011) , 10.1200/JCO.2011.34.6056
Melanie D. Seal, Stephen K. Chia, What Is the Difference Between Triple-Negative and Basal Breast Cancers? The Cancer Journal. ,vol. 16, pp. 12- 16 ,(2010) , 10.1097/PPO.0B013E3181CF04BE
Richard M. Elledge, Stephanie Green, Reginald Pugh, D. Craig Allred, Gary M. Clark, Julian Hill, Peter Ravdin, Silvana Martino, C. Kent Osborne, Estrogen receptor (ER) and progesterone receptor (PGR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer : A southwest oncology group study International Journal of Cancer. ,vol. 89, pp. 111- 117 ,(2000) , 10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.0.CO;2-W
Clifford A. Hudis, William E. Barlow, Joseph P. Costantino, Robert J. Gray, Kathleen I. Pritchard, Judith-Anne W. Chapman, Joseph A. Sparano, Sally Hunsberger, Rebecca A. Enos, Richard D. Gelber, Jo Anne Zujewski, Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System Journal of Clinical Oncology. ,vol. 25, pp. 2127- 2132 ,(2007) , 10.1200/JCO.2006.10.3523
Charles M. Perou, Therese Sørlie, Michael B. Eisen, Matt van de Rijn, Stefanie S. Jeffrey, Christian A. Rees, Jonathan R. Pollack, Douglas T. Ross, Hilde Johnsen, Lars A. Akslen, Øystein Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley X. Zhu, Per E. Lønning, Anne-Lise Børresen-Dale, Patrick O. Brown, David Botstein, Molecular portraits of human breast tumours Nature. ,vol. 406, pp. 747- 752 ,(2000) , 10.1038/35021093
Joyce O'Shaughnessy, Cynthia Osborne, John E. Pippen, Mark Yoffe, Debra Patt, Christine Rocha, Ingrid Chou Koo, Barry M. Sherman, Charles Bradley, Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer The New England Journal of Medicine. ,vol. 364, pp. 205- 214 ,(2011) , 10.1056/NEJMOA1011418
T. Sorlie, C. M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. B. Eisen, M. van de Rijn, S. S. Jeffrey, T. Thorsen, H. Quist, J. C. Matese, P. O. Brown, D. Botstein, P. E. Lonning, A.-L. Borresen-Dale, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 10869- 10874 ,(2001) , 10.1073/PNAS.191367098
Joel S. Parker, Michael Mullins, Maggie C.U. Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J.S. Marron, Andrew B. Nobel, Elaine Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard, Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes Journal of Clinical Oncology. ,vol. 27, pp. 1160- 1167 ,(2009) , 10.1200/JCO.2008.18.1370